… to the overdiagnosis of differentiated thyroid cancer (DTC). The incidence rates of medullary
thyroid cancer (MTC), follicular thyroid cancer (FTC), and anaplastic thyroid cancer (ATC) …

… low‐risk well‐differentiated thyroid cancer; better definition of … of thyroid cancer has improved
thyroid cancer diagnosis and … follicular cell‐derived thyroid cancer and point toward areas …

… Thyroid cancer is the most common malignancy of the endocrine system, encompassing …
The diagnostic definition, therapeutic approach, and follow-up of thyroid cancers display some …

… However, the landscape of thyroid cancer treatment has … the current status of advanced
thyroid cancer treatment options and … to clinically benefit patients with advanced thyroid cancer. …

… as differentiated thyroid cancer (DTC), poorly differentiated thyroid cancer (PDTC)… thyroid
cancer (ATC)—all of which are derived from thyroid follicular cells—or medullary thyroid cancer …

… FDA)-approved treatments for thyroid cancer has expanded. In … In this article, recent approvals
relevant to thyroid cancer will … in thyroid cancer therapy and selected opportunities for new …

… The molecular pathogenesis of thyroid cancer involves dysregulation of the mitogen-… ,
and activating mutations in TERT promoter are frequent in undifferentiated thyroid cancer. …

… in the diagnoses of thyroid cancers and to more thyroid surgeries being performed. Small
papillary thyroid cancers account for most of this increase in diagnoses. These cancers are …

… Furthermore, the application of RNAi agents such as small interfering RNA (siRNA) provides
novel opportunities for the management of thyroid cancers with specific genetic mutations. …

… has led to considerable gains in gene-specific systemic therapies for many cancers… thyroid
cancers and medullary thyroid cancer and highlights advancements in treating thyroid cancer …